Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Monarch Pharmaceuticals, Inc history
Monarch Pharmaceuticals, Inc company history timeline
When Hoechst merged with Marion Merrill Dow in 1995, Jefferson Gregory attempted to pry away Altace but at this juncture his bid was turned down.
To help fund its expansion, King went public in June 1998.
Due in large part to the success of Altace, King experienced robust growth since going public in 1998, when at year's end revenues and net income totaled $261.6 million and $79.5 million, respectively.
In 1999 the company purchased the antibiotic Lorabid from Eli Lilly for $91.7 million.
In 2000 King Pharmaceuticals International struck a deal with Tecnofarma, S.A. to distribute the company's estrogen replacement product, Menest, throughout Latin America.
In 2001 the company posted sales of more than $825 million and profits of nearly $218 million.
Rate how well Monarch Pharmaceuticals, Inc lives up to its initial vision.
Monarch Pharmaceuticals, Inc jobs
Do you work at Monarch Pharmaceuticals, Inc?
Does Monarch Pharmaceuticals, Inc communicate its history to new hires?
Monarch Pharmaceuticals, Inc competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| PDI | 1987 | $22.0M | 350 | 63 |
| Ascend Therapeutics | 2001 | $4.3M | 125 | - |
| Cornerstone Therapeutics | 2000 | $116.1M | 75 | - |
| Warner Chilcott | 1968 | $105.1M | 3,000 | - |
| Sunovion Pharmaceuticals | 1984 | $600.0M | 2,400 | 13 |
| Meda in the US | 2001 | $80.0M | 149 | - |
| Forest Pharmaceuticals Inc | 1954 | $40.0M | 50 | - |
| Sebela Pharmaceuticals | 2013 | $5.0M | 222 | - |
| Organon | - | $6.4B | 158 | 77 |
| Nestlé Health Science-pamlab | - | $250,000 | 15 | - |
Monarch Pharmaceuticals, Inc history FAQs
Zippia gives an in-depth look into the details of Monarch Pharmaceuticals, Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Monarch Pharmaceuticals, Inc. The employee data is based on information from people who have self-reported their past or current employments at Monarch Pharmaceuticals, Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Monarch Pharmaceuticals, Inc. The data presented on this page does not represent the view of Monarch Pharmaceuticals, Inc and its employees or that of Zippia.
Monarch Pharmaceuticals, Inc may also be known as or be related to Monarch Pharmaceuticals, Monarch Pharmaceuticals Inc and Monarch Pharmaceuticals, Inc.